Herantis Pharma’s financial calendar and annual general meeting for 2023
Herantis Pharma Plc Company release 15 Dec 2022 at 9:00 am EET Herantis Pharma Plc (“Herantis”), an innovative biotech company developing new disease-modifying therapies for Parkinson’s disease, hereby publishes the financial calendar for 2023. Financial year 2022: +-----------------------------------------+--------------------------+|Quiet period before 2H and FY 2022 report|February 1 – March 2, 2023|+-----------------------------------------+--------------------------+|2H and FY 2022 report |March 2, 2023 |+----------------